Home › Trial NCT03400306
A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian Cancer
- Trial IDNCT03400306
- StatusWithdrawn
- PhasePhase 1
- Study typeInterventional
- SponsorAbbVie
- Enrollment—
- Start date2021-11-15
- ConditionsCancer - Ovarian
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.